Bending the rule of monotherapy for migraine prevention?

Headache

Volumn 45, Issue 6, 2005, Pages 748-750

  Evans, Randolph W ^b   Pascual, Julio ^a   Láinez, Miguel J A ^b   Leira, Rogelio ^b  

^a HOSPITAL UNIVERSITARIO MARQUÉS DE VALDECILLA   (Spain)

^b NONE

Author keywords

Combined therapy; Migraine prevention; Polytherapy

Indexed keywords

AMITRIPTYLINE; ANTICONVULSIVE AGENT; ANTIMIGRAINE AGENT; ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; FLUNARIZINE; NADOLOL; NONSTEROID ANTIINFLAMMATORY AGENT; PROPRANOLOL; RIBOFLAVIN; SEROTONIN AGONIST; TOPIRAMATE; TRICYCLIC ANTIDEPRESSANT AGENT; VALPROATE SEMISODIUM;

DRUG EFFICACY; DRUG INDICATION; DRUG MECHANISM; DRUG TOLERABILITY; HEADACHE; HUMAN; MIGRAINE; MIGRAINE WITHOUT AURA; MONOTHERAPY; NEUROMODULATION; NEUROTOXICITY; NOTE; PRIORITY JOURNAL; SIDE EFFECT; WEIGHT GAIN;

ADRENERGIC BETA-ANTAGONISTS; ADULT; AMITRIPTYLINE; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; MIGRAINE DISORDERS; PROPRANOLOL; VALPROIC ACID;

EID: 20444365446     PISSN: 00178748     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1526-4610.2005.05142.x     Document Type: Note

References (10)

1. Tfelt-Hansen P, Welch KMA. Prioritizing prophylactic treatment of migraine. In: Olesen J, Tfelt-Hansen P, Welch KMA, eds. The Headaches. 2nd Edition. Philadelphia: Lippincott, Williams & Wilkins; 2000:499-500.
2. Tfelt-Hansen P, Welch KMA. General principles of pharmacological treatment of migraine. In: Olesen J, Tfelt-Hansen P, Welch KMA, eds. The Headaches. 2nd Edition. Philadelphia: Lippincott, Williams & Wilkins, 2000:385-390.
3. Pascual J, Leira R, Laínez JM. Combined therapy for migraine prevention? Clinical experience with a β-blocker plus sodium valproate in 52 resistant migraine patients. Cephalalgia. 2003;23:961-962.
4. Silberstein SD. Migraine and pregnancy. Neurol Clin. 1997;15:209-231.
5. Schoenen J, Jacquy J, Lenaerts M. Effectiveness of high-dose riboflavin in migraine prophylaxis. A randomized controlled trial. Neurology. 1998;50:466-470.
6. Boehnke C, Reuter U, Flach U, Schuh-Hofer S, Einhaupl KM, Arnold G. High-dose riboflavin treatment is efficacious in migraine prophylaxis: an open study in a terciary care centre. Eur J Neurol. 2004;11:475-477.
7. Peickert A, Wilimzig C, Kohne-Volland R. Prophylaxis of migraine with oral magnesium: results from a prospective, multicenter, placebo-controlled and double-blind randomized study. Cephalalgia. 1996;16:257-263.
8. Pascual J, Caminero AB, Mateos V, Roig C, Leira R, García- Moncó JC, Laínez M. Preventing disturbing migraine aura with lamotrigine: an open study. Headache. 2004;44:1024-1028.
9. Krymchantowski AV. Acute treatment of migraine. Breaking the paradigm of monotherapy. BCM Neurology 2004. Available at: http://www. biomedcentral.com/ 1471-2377/4/4.
10. Krymchantowski AV, Barbosa JS. Rizatriptan combined with rofecoxib vs rizatriptan for the acute treatment of migraine: an open pilot study. Cephalalgia. 2002;22:309-312.